Cite
Wang J, Li YC, Deng M, et al. Serum insulin-like growth factor-1 and its binding protein 3 as prognostic factors for the incidence, progression, and outcome of hepatocellular carcinoma: a systematic review and meta-analysis. Oncotarget. 2017;8(46):81098-81108doi: 10.18632/oncotarget.19186.
Wang, J., Li, Y. C., Deng, M., Jiang, H. Y., Guo, L. H., Zhou, W. J., & Ruan, B. (2017). Serum insulin-like growth factor-1 and its binding protein 3 as prognostic factors for the incidence, progression, and outcome of hepatocellular carcinoma: a systematic review and meta-analysis. Oncotarget, 8(46), 81098-81108. https://doi.org/10.18632/oncotarget.19186
Wang, Jing, et al. "Serum insulin-like growth factor-1 and its binding protein 3 as prognostic factors for the incidence, progression, and outcome of hepatocellular carcinoma: a systematic review and meta-analysis." Oncotarget vol. 8,46 (2017): 81098-81108. doi: https://doi.org/10.18632/oncotarget.19186
Wang J, Li YC, Deng M, Jiang HY, Guo LH, Zhou WJ, Ruan B. Serum insulin-like growth factor-1 and its binding protein 3 as prognostic factors for the incidence, progression, and outcome of hepatocellular carcinoma: a systematic review and meta-analysis. Oncotarget. 2017 Jul 12;8(46):81098-81108. doi: 10.18632/oncotarget.19186. eCollection 2017 Oct 06. PMID: 29113370; PMCID: PMC5655265.
Copy
Download .nbib